Sign inGet started

OBERMAN ALLAN

Insider CIK 1656585 · SGNT Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SGNT Sagent Pharmaceuticals, In D To issuer deriv2016-08-292016-08-31108,696$7.14 $776.1K0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer2016-08-292016-08-3192,527$21.75 $2.01M0SEC↗
SGNT Sagent Pharmaceuticals, In D To issuer2016-08-292016-08-319,459$21.75 $205.7K92,527SEC↗
SGNT Sagent Pharmaceuticals, In F Tax w/h2016-08-032016-08-054,271$21.74 $92.9K101,986SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2016-02-222016-02-23108,696— $0108,696SEC↗
SGNT Sagent Pharmaceuticals, In A Award2016-02-222016-02-2351,335— $0106,257SEC↗
SGNT Sagent Pharmaceuticals, In A Award deriv2015-08-032015-12-02110,020— $0110,020SEC↗
SGNT Sagent Pharmaceuticals, In A Award2015-08-032015-12-0254,922— $054,922SEC↗